Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Lenz, J.H.
3353  Ergebnisse:
Personensuche X
?
1

Exploring the differences in the tumor microenvironment and..:

Faber, E.B. ; Baca, Y. ; Xiu, J....
ESMO Gastrointestinal Oncology.  4 (2024)  - p. 100042 , 2024
Link: https://doi.org/10.1016/..
 
?
2

2O Health-related quality of life (HRQoL) with first-line (..:

Lonardi, S. ; André, T. ; Arnold, D....
Annals of Oncology.  35 (2024)  - p. S1-S2 , 2024
Link: https://doi.org/10.1016/..
 
?
3

485P Heterogeneity and dynamic changes of PD-L1 expression ..:

Salem, M.E. ; Wu, S. ; Xiu, J....
Annals of Oncology.  35 (2024)  - p. S193 , 2024
Link: https://doi.org/10.1016/..
 
?
4

128P Real-world survival outcomes in MSS colorectal cancer(..:

Malla, M. ; Deshmukh, S.K. ; Wu, S....
Annals of Oncology.  35 (2024)  - p. S59-S60 , 2024
Link: https://doi.org/10.1016/..
 
?
5

484P Clinical and biologic characteristic of gastro-esophag..:

Grothey, A. ; Fifield, A. ; Sweeney, K....
Annals of Oncology.  35 (2024)  - p. S192-S193 , 2024
Link: https://doi.org/10.1016/..
 
?
6

116TiP Randomized, open-label, phase II study of botensilim..:

Van Cutsem, E. ; Fakih, M. ; Segal, N.H....
Immuno-Oncology and Technology.  20 (2023)  - p. 100588 , 2023
Link: https://doi.org/10.1016/..
 
?
7

Nivolumab plus low-dose ipilimumab in previously treated pa..:

André, T. ; Lonardi, S. ; Wong, K.Y.M....
Annals of Oncology.  33 (2022)  10 - p. 1052-1060 , 2022
Link: https://doi.org/10.1016/..
 
?
8

Dynamic changes in RAS gene status in circulating tumour DN..:

Sunakawa, Y. ; Satake, H. ; Usher, J....
ESMO Open.  7 (2022)  3 - p. 100512 , 2022
Link: https://doi.org/10.1016/..
 
?
9

Correction to: KSR1 regulates BRCA1 degradation and inhibit..:

Stebbing, J. ; Zhang, H. ; Xu, Y....
Oncogene.  40 (2021)  19 - p. 3473-3473 , 2021
Link: https://doi.org/10.1038/..
 
?
10

Correction: KSR1 regulates BRCA1 degradation and inhibits b..:

Stebbing, J. ; Zhang, H. ; Xu, Y....
Oncogene.  , 2021
Link: https://doi.org/10.1038/..
 
?
11

A phase II study of Guadecitabine (G) with Irinotecan (IRI)..:

Lee, V. ; Zahurak, M. ; Cercek, A....
European Journal of Cancer.  138 (2020)  - p. S12 , 2020
Link: https://doi.org/10.1016/..
 
?
12

Consensus molecular subgroups (CMS) of colorectal cancer (C..:

Stintzing, S. ; Wirapati, P. ; Lenz, H.-J....
Annals of Oncology.  30 (2019)  11 - p. 1796-1803 , 2019
Link: https://doi.org/10.1093/..
 
?
13

Nintedanib for the treatment of patients with refractory me..:

Van Cutsem, E. ; Yoshino, T. ; Lenz, H.J....
Annals of Oncology.  29 (2018)  9 - p. 1955-1963 , 2018
Link: https://doi.org/10.1093/..
 
?
14

Genetic variants of DNA repair-related genes predict effica..:

Suenaga, M. ; Schirripa, M. ; Cao, S....
Annals of Oncology.  28 (2017)  5 - p. 1015-1022 , 2017
Link: https://doi.org/10.1093/..
 
?
15

Five‐year mortality in patients treated for severe communit..:

Lenz, H. ; Norby, G. O. ; Dahl, V...
Acta Anaesthesiologica Scandinavica.  61 (2017)  4 - p. 418-426 , 2017
Link: https://doi.org/10.1111/..
 
1-15